360 High-Risk Vulnerability Immunization Tool V2.0 vs OpenAVN (Brightscan & Torus): Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

OpenAVN (Brightscan & Torus): AI-powered antivirus suite with browser extension for endpoint & web protection. built by DefenseArk (OpenAVN). Core capabilities include AI-powered malware scanning, Crowdsourced threat intelligence, Zero-knowledge privacy model (no personal data parsing)..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. OpenAVN (Brightscan & Torus) differentiates with AI-powered malware scanning, Crowdsourced threat intelligence, Zero-knowledge privacy model (no personal data parsing).

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). OpenAVN (Brightscan & Torus) is developed by DefenseArk (OpenAVN). Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and OpenAVN (Brightscan & Torus) serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.